XML 54 R2.htm IDEA: XBRL DOCUMENT
v3.24.0.1

Pay vs Performance Disclosure - USD ($) | 12 Months Ended
--- | ---
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020
Pay vs Performance Disclosure |  |  |  |
Pay vs Performance Disclosure, Table | 2023 Pay Versus Performance Table The following table sets forth additional compensation information of our Principal Executive Officer (“PEO”) and our non-PEO Named Executive Officers (“non-PEO NEOs”) along with total shareholder return, net income attributable to HCA Healthcare, Inc. and adjusted EBITDA performance results for our fiscal years ending in 2023, 2022, 2021 and 2020. “Compensation actually paid” does not represent the value of cash and shares of the Company’s common stock received by named executive officers during the year, but rather it is an amount calculated under SEC rules and includes, among other things, year-over-year changes in the value of unvested equity based awards. As a result of the calculation methodology required by the SEC, “Compensation actually paid” amounts differ from compensation actually received by the individuals and the compensation decisions described in the “Compensation Discussion and Analysis” section above.
Year |  | Summary Compensation Table Total for PEO (1) |  |  | Compensation Actually Paid to PEO (2)(3)(4) |  |  | Average Summary Compensation Table Total for non-PEO NEOs (1) |  |  | Average Compensation Actually Paid to non-PEO NEOs (2)(3)(4) |  |  | Value of Initial Fixed $100 Investment Based On: |  |  | Net Income Attributable to HCA Healthcare, Inc. |  |  | Adjusted EBITDA (10) |
| Total Shareholder Return |  |  | Peer Group Total Shareholder Return (9) |
2023 (5) |  |  | $21,315,984 |  |  |  | $23,591,845 |  |  |  | $6,861,426 |  |  |  | $ 7,050,413 |  |  |  | $188.93 |  |  |  | $143.18 |  |  |  | $5,242,000,000 |  |  |  | $12,726,000,000 |
2022 (6) |  |  | $14,637,726 |  |  |  | $ 9,582,202 |  |  |  | $5,166,993 |  |  |  | $ 3,405,676 |  |  |  | $165.99 |  |  |  | $140.29 |  |  |  | $5,643,000,000 |  |  |  | $12,067,000,000 |
2021 (7) |  |  | $20,635,260 |  |  |  | $84,568,577 |  |  |  | $5,999,564 |  |  |  | $19,628,647 |  |  |  | $175.93 |  |  |  | $143.09 |  |  |  | $6,956,000,000 |  |  |  | $12,644,000,000 |
2020 (8) |  |  | $30,397,771 |  |  |  | $30,452,042 |  |  |  | $7,041,315 |  |  |  | $ 7,875,351 |  |  |  | $111.64 |  |  |  | $113.45 |  |  |  | $3,754,000,000 |  |  |  | $10,037,000,000 |
(1) | Named executive officers included in the above compensation columns reflect the following:
|  | Year |  | PEO |  |  | Non-PEO NEOs
|  | 2023 |  |  | Hazen |  |  | Rutherford, Foster, Akdamar, McManus
|  | 2022 |  |  | Hazen |  |  | Rutherford, Foster, Hall, McAlevey
|  | 2021 |  |  | Hazen |  |  | Rutherford, Foster, Hall, Cuffe
|  | 2020 |  |  | Hazen |  |  | Rutherford, Foster, Hall, Perlin
(2) | Fair value or change in fair value, as applicable, of equity awards in the “Actually Paid” columns was determined by reference to (1) for PSU awards, closing price on applicable year-end date(s) multiplied by the probability of achievement as of each such date or, in the case of vesting dates, the actual shares earned multiplied by the vesting price, (2) for SAR awards, a Black-Scholes value as of the applicable year-end or vesting date(s), determined based on the same methodology as used to determine grant date fair value for the applicable grant and (3) for RSU awards, the closing price on applicable year-end date(s) or, in the case of vesting dates, the actual vesting price.
(3) | For the portion of “Actually Paid” compensation that is based on year-end stock prices, the following prices were used: $270.68 for 2023 (closing price as of 12/29/23), $239.96 for 2022 (closing price as of 12/30/22), $256.92 for 2021 (closing price as of 12/31/21) and $164.46 for 2020 (closing price as of 12/31/20).
(4) | Amounts for 2020-2022 have been revised from the prior year presentation to value certain PSU awards at the vesting date rather than the performance certification date.
(5) | 2023 “Compensation Actually Paid to PEO” and “Average Compensation Actually Paid to non-PEO NEOs” reflects the following adjustments from 2023 Total Compensation reported in the Summary Compensation Table:
|  | PEO |  |  | Average non-PEO NEOs |
2023 Summary Compensation Table Total |  | $ | 21,315,984 |  |  | $ | 6,861,426 |
Less: Change in Pension & Deferred Compensation Plans |  |  | — |  |  | $ | 264,662 |
Add: Service Cost of Pension & Deferred Compensation Plans |  | $ | 723,544 |  |  | $ | 135,006 |
Add: Prior Service Cost of Pension & Deferred Compensation Plans |  |  | — |  |  |  | — |
Add: Above-Market or Preferential Earnings on Deferred Compensation |  |  | — |  |  |  | — |
Less: Equity Award Amounts Reported in Summary Compensation Table |  | $ | 14,200,216 |  |  | $ | 3,489,375 |
Add: FMV of Equity Awards Granted During Current Year & Outstanding/Unvested @ 12/31/23 |  | $ | 15,028,391 |  |  | $ | 3,692,881 |
Add: Change in FMV Equity Awards Granted in Prior Years & Outstanding/Unvested @ 12/31/23 |  | $ | (2,830,010 | ) |  | $ | (482,970 | )
Add: FMV of Equity Awards Granted and Vested in Current Year @ Vesting Date |  |  | — |  |  |  | — |
Add: Change in FMV of Equity Awards Granted in Prior Years @ Vesting Date |  | $ | 3,842,051 |  |  | $ | 642,477 |
Less: FMV of Equity Awards @ the End of the Prior Year Failing to Meet Vesting Conditions |  |  | — |  |  |  | — |
Less: Dollar Value of Equivalent Payments Reported in Summary Compensation Table |  | $ | 514,566 |  |  | $ | 85,739 |
Add: Dollar Value of Dividends Paid Prior to Vesting Date |  | $ | 226,667 |  |  | $ | 41,399 |
2023 Compensation Actually Paid |  | $ | 23,591,845 |  |  | $ | 7,050,413 |
(6) | 2022 “Compensation Actually Paid to PEO” and “Average Compensation Actually Paid to non-PEO NEOs” reflects the following adjustments from 2022 Total Compensation reported in the Summary Compensation Table:
|  | PEO |  |  | Average non-PEO NEOs |
2022 Summary Compensation Table Total |  | $ | 14,637,726 |  |  | $ | 5,166,993 |
Less: Change in Pension & Deferred Compensation Plans |  |  | — |  |  | $ | 276,883 |
Add: Service Cost of Pension & Deferred Compensation Plans |  | $ | 952,610 |  |  | $ | 182,990 |
Add: Prior Service Cost of Pension & Deferred Compensation Plans |  |  | — |  |  |  | — |
Add: Above-Market or Preferential Earnings on Deferred Compensation |  |  | — |  |  |  | — |
Less: Equity Award Amounts Reported in Summary Compensation Table |  | $ | 12,055,290 |  |  | $ | 3,063,442 |
Add: FMV of Equity Awards Granted During Current Year & Outstanding/Unvested @ 12/31/22 |  | $ | 13,374,858 |  |  | $ | 2,698,985 |
Add: Change in FMV Equity Awards Granted in Prior Years & Outstanding/Unvested @ 12/31/22 (4) |  | $ | (3,338,709 | ) |  | $ | (573,313 | )
Add: FMV of Equity Awards Granted and Vested in Current Year @ Vesting Date |  |  | — |  |  |  | — |
Add: Change in FMV of Equity Awards Granted in Prior Years @ Vesting Date (4) |  | $ | (3,998,784 | ) |  | $ | (737,029 | )
Less: FMV of Equity Awards @ the End of the Prior Year Failing to Meet Vesting Conditions |  |  | — |  |  |  | — |
Less: Dollar Value of Equivalent Payments Reported in Summary Compensation Table |  | $ | 435,499 |  |  | $ | 73,188 |
Add: Dollar Value of Dividends Paid Prior to Vesting Date |  | $ | 445,290 |  |  | $ | 80,563 |
2022 Compensation Actually Paid |  | $ | 9,582,202 |  |  | $ | 3,405,676 |
(7) | 2021 “Compensation Actually Paid to PEO” and “Average Compensation Actually Paid to non-PEO NEOs” reflects the following adjustments from 2021 Total Compensation reported in the Summary Compensation Table:
|  | PEO |  |  | Average non-PEO NEOs |
2021 Summary Compensation Table Total |  | $ | 20,635,260 |  |  | $ | 5,999,564 |
Less: Change in Pension & Deferred Compensation Plans |  | $ | 451,661 |  |  | $ | 103,724 |
Add: Service Cost of Pension & Deferred Compensation Plans |  | $ | 980,231 |  |  | $ | 207,139 |
Add: Prior Service Cost of Pension & Deferred Compensation Plans |  |  | — |  |  |  | — |
Add: Above-Market or Preferential Earnings on Deferred Compensation |  |  | — |  |  |  | — |
Less: Equity Award Amounts Reported in Summary Compensation Table |  | $ | 13,870,607 |  |  | $ | 3,233,944 |
Add: FMV of Equity Awards Granted During Current Year & Outstanding/Unvested @ 12/31/21 |  | $ | 34,793,801 |  |  | $ | 7,765,175 |
Add: Change in FMV Equity Awards Granted in Prior Years & Outstanding/Unvested @ 12/31/21 (4) |  | $ | 33,207,890 |  |  | $ | 7,116,946 |
Add: FMV of Equity Awards Granted and Vested in Current Year @ Vesting Date |  |  | — |  |  |  | — |
Add: Change in FMV of Equity Awards Granted in Prior Years @ Vesting Date (4) |  | $ | 9,064,316 |  |  | $ | 1,834,093 |
Less: FMV of Equity Awards @ the End of the Prior Year Failing to Meet Vesting Conditions |  |  | — |  |  |  | — |
Less: Dollar Value of Equivalent Payments Reported in Summary Compensation Table |  | $ | 335,908 |  |  | $ | 67,999 |
Add: Dollar Value of Dividends Paid Prior to Vesting Date |  | $ | 545,255 |  |  | $ | 111,397 |
2021 Compensation Actually Paid |  | $ | 84,568,577 |  |  | $ | 19,628,647 |
(8) | 2020 “Compensation Actually Paid to PEO” and “Average Compensation Actually Paid to non-PEO NEOs” reflects the following adjustments from 2020 Total Compensation reported in the Summary Compensation Table:
|  | PEO |  |  | Average non-PEO NEOs |
2020 Summary Compensation Table Total |  | $ | 30,397,771 |  |  | $ | 7,041,315 |
Less: Change in Pension & Deferred Compensation Plans |  | $ | 12,266,548 |  |  | $ | 2,112,322 |
Add: Service Cost of Pension & Deferred Compensation Plans |  | $ | 645,000 |  |  | $ | 325,250 |
Add: Prior Service Cost of Pension & Deferred Compensation Plans |  |  | — |  |  |  | — |
Add: Above-Market or Preferential Earnings on Deferred Compensation |  |  | — |  |  |  | — |
Less: Equity Award Amounts Reported in Summary Compensation Table |  | $ | 13,082,198 |  |  | $ | 2,617,165 |
Add: FMV of Equity Awards Granted During Current Year & Outstanding/Unvested @ 12/31/20 |  | $ | 16,696,602 |  |  | $ | 3,335,797 |
Add: Change in FMV Equity Awards Granted in Prior Years & Outstanding/Unvested @ 12/31/20 (4) |  | $ | 8,028,998 |  |  | $ | 1,883,050 |
Add: FMV of Equity Awards Granted and Vested in Current Year @ Vesting Date |  |  | — |  |  |  | — |
Add: Change in FMV of Equity Awards Granted in Prior Years @ Vesting Date (4) |  | $ | 89,497 |  |  | $ | 60,407 |
Less: FMV of Equity Awards @ the End of the Prior Year Failing to Meet Vesting Conditions |  |  | — |  |  |  | — |
Less: Dollar Value of Equivalent Payments Reported in Summary Compensation Table |  | $ | 166,818 |  |  | $ | 66,927 |
Add: Dollar Value of Dividends Paid Prior to Vesting Date |  | $ | 109,738 |  |  | $ | 25,946 |
2020 Compensation Actually Paid |  | $ | 30,452,042 |  |  | $ | 7,875,351 |
(9) | The Peer Group reflected in the Peer Group Total Shareholder Return is the S&P Health Care Index, as reflected in our 2023 Annual Report on Form the 10-K pursuant to Item 201(e) of Regulation S-K. Each year reflects the cumulative total return assuming $100 invested on December 31, 2019 in our common stock and in the S&P Health Care Index, including the subsequent reinvestment of dividends.
(10) | Adjusted EBITDA was selected by the Compensation Committee as the Company-Selected Measure (“CSM”). It is a non-Generally Accepted Accounting Principles (“GAAP”) financial measure defined as income before depreciation and amortization, interest expense, losses and gains on sales of facilities, losses on retirement of debt, provision for income taxes and net income attributable to noncontrolling interests. Reconciliations of Adjusted EBITDA to the most directly comparable financial measure calculated in accordance with GAAP are included in Appendix A.
Company Selected Measure Name | Adjusted EBITDA |  |  |
Named Executive Officers, Footnote |
(1) | Named executive officers included in the above compensation columns reflect the following:
|  | Year |  | PEO |  |  | Non-PEO NEOs
|  | 2023 |  |  | Hazen |  |  | Rutherford, Foster, Akdamar, McManus
|  | 2022 |  |  | Hazen |  |  | Rutherford, Foster, Hall, McAlevey
|  | 2021 |  |  | Hazen |  |  | Rutherford, Foster, Hall, Cuffe
|  | 2020 |  |  | Hazen |  |  | Rutherford, Foster, Hall, Perlin
Peer Group Issuers, Footnote | The Peer Group reflected in the Peer Group Total Shareholder Return is the S&P Health Care Index, as reflected in our 2023 Annual Report on Form the 10-K pursuant to Item 201(e) of Regulation S-K. Each year reflects the cumulative total return assuming $100 invested on December 31, 2019 in our common stock and in the S&P Health Care Index, including the subsequent reinvestment of dividends. |  |  |
PEO Total Compensation Amount | $ 21,315,984 | $ 14,637,726 | $ 20,635,260 | $ 30,397,771
PEO Actually Paid Compensation Amount | $ 23,591,845 | 9,582,202 | 84,568,577 | 30,452,042
Adjustment To PEO Compensation, Footnote |
(5) | 2023 “Compensation Actually Paid to PEO” and “Average Compensation Actually Paid to non-PEO NEOs” reflects the following adjustments from 2023 Total Compensation reported in the Summary Compensation Table:
|  | PEO |  |  | Average non-PEO NEOs |
2023 Summary Compensation Table Total |  | $ | 21,315,984 |  |  | $ | 6,861,426 |
Less: Change in Pension & Deferred Compensation Plans |  |  | — |  |  | $ | 264,662 |
Add: Service Cost of Pension & Deferred Compensation Plans |  | $ | 723,544 |  |  | $ | 135,006 |
Add: Prior Service Cost of Pension & Deferred Compensation Plans |  |  | — |  |  |  | — |
Add: Above-Market or Preferential Earnings on Deferred Compensation |  |  | — |  |  |  | — |
Less: Equity Award Amounts Reported in Summary Compensation Table |  | $ | 14,200,216 |  |  | $ | 3,489,375 |
Add: FMV of Equity Awards Granted During Current Year & Outstanding/Unvested @ 12/31/23 |  | $ | 15,028,391 |  |  | $ | 3,692,881 |
Add: Change in FMV Equity Awards Granted in Prior Years & Outstanding/Unvested @ 12/31/23 |  | $ | (2,830,010 | ) |  | $ | (482,970 | )
Add: FMV of Equity Awards Granted and Vested in Current Year @ Vesting Date |  |  | — |  |  |  | — |
Add: Change in FMV of Equity Awards Granted in Prior Years @ Vesting Date |  | $ | 3,842,051 |  |  | $ | 642,477 |
Less: FMV of Equity Awards @ the End of the Prior Year Failing to Meet Vesting Conditions |  |  | — |  |  |  | — |
Less: Dollar Value of Equivalent Payments Reported in Summary Compensation Table |  | $ | 514,566 |  |  | $ | 85,739 |
Add: Dollar Value of Dividends Paid Prior to Vesting Date |  | $ | 226,667 |  |  | $ | 41,399 |
2023 Compensation Actually Paid |  | $ | 23,591,845 |  |  | $ | 7,050,413 |
(6) | 2022 “Compensation Actually Paid to PEO” and “Average Compensation Actually Paid to non-PEO NEOs” reflects the following adjustments from 2022 Total Compensation reported in the Summary Compensation Table:
|  | PEO |  |  | Average non-PEO NEOs |
2022 Summary Compensation Table Total |  | $ | 14,637,726 |  |  | $ | 5,166,993 |
Less: Change in Pension & Deferred Compensation Plans |  |  | — |  |  | $ | 276,883 |
Add: Service Cost of Pension & Deferred Compensation Plans |  | $ | 952,610 |  |  | $ | 182,990 |
Add: Prior Service Cost of Pension & Deferred Compensation Plans |  |  | — |  |  |  | — |
Add: Above-Market or Preferential Earnings on Deferred Compensation |  |  | — |  |  |  | — |
Less: Equity Award Amounts Reported in Summary Compensation Table |  | $ | 12,055,290 |  |  | $ | 3,063,442 |
Add: FMV of Equity Awards Granted During Current Year & Outstanding/Unvested @ 12/31/22 |  | $ | 13,374,858 |  |  | $ | 2,698,985 |
Add: Change in FMV Equity Awards Granted in Prior Years & Outstanding/Unvested @ 12/31/22 (4) |  | $ | (3,338,709 | ) |  | $ | (573,313 | )
Add: FMV of Equity Awards Granted and Vested in Current Year @ Vesting Date |  |  | — |  |  |  | — |
Add: Change in FMV of Equity Awards Granted in Prior Years @ Vesting Date (4) |  | $ | (3,998,784 | ) |  | $ | (737,029 | )
Less: FMV of Equity Awards @ the End of the Prior Year Failing to Meet Vesting Conditions |  |  | — |  |  |  | — |
Less: Dollar Value of Equivalent Payments Reported in Summary Compensation Table |  | $ | 435,499 |  |  | $ | 73,188 |
Add: Dollar Value of Dividends Paid Prior to Vesting Date |  | $ | 445,290 |  |  | $ | 80,563 |
2022 Compensation Actually Paid |  | $ | 9,582,202 |  |  | $ | 3,405,676 |
(7) | 2021 “Compensation Actually Paid to PEO” and “Average Compensation Actually Paid to non-PEO NEOs” reflects the following adjustments from 2021 Total Compensation reported in the Summary Compensation Table:
|  | PEO |  |  | Average non-PEO NEOs |
2021 Summary Compensation Table Total |  | $ | 20,635,260 |  |  | $ | 5,999,564 |
Less: Change in Pension & Deferred Compensation Plans |  | $ | 451,661 |  |  | $ | 103,724 |
Add: Service Cost of Pension & Deferred Compensation Plans |  | $ | 980,231 |  |  | $ | 207,139 |
Add: Prior Service Cost of Pension & Deferred Compensation Plans |  |  | — |  |  |  | — |
Add: Above-Market or Preferential Earnings on Deferred Compensation |  |  | — |  |  |  | — |
Less: Equity Award Amounts Reported in Summary Compensation Table |  | $ | 13,870,607 |  |  | $ | 3,233,944 |
Add: FMV of Equity Awards Granted During Current Year & Outstanding/Unvested @ 12/31/21 |  | $ | 34,793,801 |  |  | $ | 7,765,175 |
Add: Change in FMV Equity Awards Granted in Prior Years & Outstanding/Unvested @ 12/31/21 (4) |  | $ | 33,207,890 |  |  | $ | 7,116,946 |
Add: FMV of Equity Awards Granted and Vested in Current Year @ Vesting Date |  |  | — |  |  |  | — |
Add: Change in FMV of Equity Awards Granted in Prior Years @ Vesting Date (4) |  | $ | 9,064,316 |  |  | $ | 1,834,093 |
Less: FMV of Equity Awards @ the End of the Prior Year Failing to Meet Vesting Conditions |  |  | — |  |  |  | — |
Less: Dollar Value of Equivalent Payments Reported in Summary Compensation Table |  | $ | 335,908 |  |  | $ | 67,999 |
Add: Dollar Value of Dividends Paid Prior to Vesting Date |  | $ | 545,255 |  |  | $ | 111,397 |
2021 Compensation Actually Paid |  | $ | 84,568,577 |  |  | $ | 19,628,647 |
(8) | 2020 “Compensation Actually Paid to PEO” and “Average Compensation Actually Paid to non-PEO NEOs” reflects the following adjustments from 2020 Total Compensation reported in the Summary Compensation Table:
|  | PEO |  |  | Average non-PEO NEOs |
2020 Summary Compensation Table Total |  | $ | 30,397,771 |  |  | $ | 7,041,315 |
Less: Change in Pension & Deferred Compensation Plans |  | $ | 12,266,548 |  |  | $ | 2,112,322 |
Add: Service Cost of Pension & Deferred Compensation Plans |  | $ | 645,000 |  |  | $ | 325,250 |
Add: Prior Service Cost of Pension & Deferred Compensation Plans |  |  | — |  |  |  | — |
Add: Above-Market or Preferential Earnings on Deferred Compensation |  |  | — |  |  |  | — |
Less: Equity Award Amounts Reported in Summary Compensation Table |  | $ | 13,082,198 |  |  | $ | 2,617,165 |
Add: FMV of Equity Awards Granted During Current Year & Outstanding/Unvested @ 12/31/20 |  | $ | 16,696,602 |  |  | $ | 3,335,797 |
Add: Change in FMV Equity Awards Granted in Prior Years & Outstanding/Unvested @ 12/31/20 (4) |  | $ | 8,028,998 |  |  | $ | 1,883,050 |
Add: FMV of Equity Awards Granted and Vested in Current Year @ Vesting Date |  |  | — |  |  |  | — |
Add: Change in FMV of Equity Awards Granted in Prior Years @ Vesting Date (4) |  | $ | 89,497 |  |  | $ | 60,407 |
Less: FMV of Equity Awards @ the End of the Prior Year Failing to Meet Vesting Conditions |  |  | — |  |  |  | — |
Less: Dollar Value of Equivalent Payments Reported in Summary Compensation Table |  | $ | 166,818 |  |  | $ | 66,927 |
Add: Dollar Value of Dividends Paid Prior to Vesting Date |  | $ | 109,738 |  |  | $ | 25,946 |
2020 Compensation Actually Paid |  | $ | 30,452,042 |  |  | $ | 7,875,351 |
Non-PEO NEO Average Total Compensation Amount | $ 6,861,426 | 5,166,993 | 5,999,564 | 7,041,315
Non-PEO NEO Average Compensation Actually Paid Amount | $ 7,050,413 | 3,405,676 | 19,628,647 | 7,875,351
Adjustment to Non-PEO NEO Compensation Footnote |
(5) | 2023 “Compensation Actually Paid to PEO” and “Average Compensation Actually Paid to non-PEO NEOs” reflects the following adjustments from 2023 Total Compensation reported in the Summary Compensation Table:
|  | PEO |  |  | Average non-PEO NEOs |
2023 Summary Compensation Table Total |  | $ | 21,315,984 |  |  | $ | 6,861,426 |
Less: Change in Pension & Deferred Compensation Plans |  |  | — |  |  | $ | 264,662 |
Add: Service Cost of Pension & Deferred Compensation Plans |  | $ | 723,544 |  |  | $ | 135,006 |
Add: Prior Service Cost of Pension & Deferred Compensation Plans |  |  | — |  |  |  | — |
Add: Above-Market or Preferential Earnings on Deferred Compensation |  |  | — |  |  |  | — |
Less: Equity Award Amounts Reported in Summary Compensation Table |  | $ | 14,200,216 |  |  | $ | 3,489,375 |
Add: FMV of Equity Awards Granted During Current Year & Outstanding/Unvested @ 12/31/23 |  | $ | 15,028,391 |  |  | $ | 3,692,881 |
Add: Change in FMV Equity Awards Granted in Prior Years & Outstanding/Unvested @ 12/31/23 |  | $ | (2,830,010 | ) |  | $ | (482,970 | )
Add: FMV of Equity Awards Granted and Vested in Current Year @ Vesting Date |  |  | — |  |  |  | — |
Add: Change in FMV of Equity Awards Granted in Prior Years @ Vesting Date |  | $ | 3,842,051 |  |  | $ | 642,477 |
Less: FMV of Equity Awards @ the End of the Prior Year Failing to Meet Vesting Conditions |  |  | — |  |  |  | — |
Less: Dollar Value of Equivalent Payments Reported in Summary Compensation Table |  | $ | 514,566 |  |  | $ | 85,739 |
Add: Dollar Value of Dividends Paid Prior to Vesting Date |  | $ | 226,667 |  |  | $ | 41,399 |
2023 Compensation Actually Paid |  | $ | 23,591,845 |  |  | $ | 7,050,413 |
(6) | 2022 “Compensation Actually Paid to PEO” and “Average Compensation Actually Paid to non-PEO NEOs” reflects the following adjustments from 2022 Total Compensation reported in the Summary Compensation Table:
|  | PEO |  |  | Average non-PEO NEOs |
2022 Summary Compensation Table Total |  | $ | 14,637,726 |  |  | $ | 5,166,993 |
Less: Change in Pension & Deferred Compensation Plans |  |  | — |  |  | $ | 276,883 |
Add: Service Cost of Pension & Deferred Compensation Plans |  | $ | 952,610 |  |  | $ | 182,990 |
Add: Prior Service Cost of Pension & Deferred Compensation Plans |  |  | — |  |  |  | — |
Add: Above-Market or Preferential Earnings on Deferred Compensation |  |  | — |  |  |  | — |
Less: Equity Award Amounts Reported in Summary Compensation Table |  | $ | 12,055,290 |  |  | $ | 3,063,442 |
Add: FMV of Equity Awards Granted During Current Year & Outstanding/Unvested @ 12/31/22 |  | $ | 13,374,858 |  |  | $ | 2,698,985 |
Add: Change in FMV Equity Awards Granted in Prior Years & Outstanding/Unvested @ 12/31/22 (4) |  | $ | (3,338,709 | ) |  | $ | (573,313 | )
Add: FMV of Equity Awards Granted and Vested in Current Year @ Vesting Date |  |  | — |  |  |  | — |
Add: Change in FMV of Equity Awards Granted in Prior Years @ Vesting Date (4) |  | $ | (3,998,784 | ) |  | $ | (737,029 | )
Less: FMV of Equity Awards @ the End of the Prior Year Failing to Meet Vesting Conditions |  |  | — |  |  |  | — |
Less: Dollar Value of Equivalent Payments Reported in Summary Compensation Table |  | $ | 435,499 |  |  | $ | 73,188 |
Add: Dollar Value of Dividends Paid Prior to Vesting Date |  | $ | 445,290 |  |  | $ | 80,563 |
2022 Compensation Actually Paid |  | $ | 9,582,202 |  |  | $ | 3,405,676 |
(7) | 2021 “Compensation Actually Paid to PEO” and “Average Compensation Actually Paid to non-PEO NEOs” reflects the following adjustments from 2021 Total Compensation reported in the Summary Compensation Table:
|  | PEO |  |  | Average non-PEO NEOs |
2021 Summary Compensation Table Total |  | $ | 20,635,260 |  |  | $ | 5,999,564 |
Less: Change in Pension & Deferred Compensation Plans |  | $ | 451,661 |  |  | $ | 103,724 |
Add: Service Cost of Pension & Deferred Compensation Plans |  | $ | 980,231 |  |  | $ | 207,139 |
Add: Prior Service Cost of Pension & Deferred Compensation Plans |  |  | — |  |  |  | — |
Add: Above-Market or Preferential Earnings on Deferred Compensation |  |  | — |  |  |  | — |
Less: Equity Award Amounts Reported in Summary Compensation Table |  | $ | 13,870,607 |  |  | $ | 3,233,944 |
Add: FMV of Equity Awards Granted During Current Year & Outstanding/Unvested @ 12/31/21 |  | $ | 34,793,801 |  |  | $ | 7,765,175 |
Add: Change in FMV Equity Awards Granted in Prior Years & Outstanding/Unvested @ 12/31/21 (4) |  | $ | 33,207,890 |  |  | $ | 7,116,946 |
Add: FMV of Equity Awards Granted and Vested in Current Year @ Vesting Date |  |  | — |  |  |  | — |
Add: Change in FMV of Equity Awards Granted in Prior Years @ Vesting Date (4) |  | $ | 9,064,316 |  |  | $ | 1,834,093 |
Less: FMV of Equity Awards @ the End of the Prior Year Failing to Meet Vesting Conditions |  |  | — |  |  |  | — |
Less: Dollar Value of Equivalent Payments Reported in Summary Compensation Table |  | $ | 335,908 |  |  | $ | 67,999 |
Add: Dollar Value of Dividends Paid Prior to Vesting Date |  | $ | 545,255 |  |  | $ | 111,397 |
2021 Compensation Actually Paid |  | $ | 84,568,577 |  |  | $ | 19,628,647 |
(8) | 2020 “Compensation Actually Paid to PEO” and “Average Compensation Actually Paid to non-PEO NEOs” reflects the following adjustments from 2020 Total Compensation reported in the Summary Compensation Table:
|  | PEO |  |  | Average non-PEO NEOs |
2020 Summary Compensation Table Total |  | $ | 30,397,771 |  |  | $ | 7,041,315 |
Less: Change in Pension & Deferred Compensation Plans |  | $ | 12,266,548 |  |  | $ | 2,112,322 |
Add: Service Cost of Pension & Deferred Compensation Plans |  | $ | 645,000 |  |  | $ | 325,250 |
Add: Prior Service Cost of Pension & Deferred Compensation Plans |  |  | — |  |  |  | — |
Add: Above-Market or Preferential Earnings on Deferred Compensation |  |  | — |  |  |  | — |
Less: Equity Award Amounts Reported in Summary Compensation Table |  | $ | 13,082,198 |  |  | $ | 2,617,165 |
Add: FMV of Equity Awards Granted During Current Year & Outstanding/Unvested @ 12/31/20 |  | $ | 16,696,602 |  |  | $ | 3,335,797 |
Add: Change in FMV Equity Awards Granted in Prior Years & Outstanding/Unvested @ 12/31/20 (4) |  | $ | 8,028,998 |  |  | $ | 1,883,050 |
Add: FMV of Equity Awards Granted and Vested in Current Year @ Vesting Date |  |  | — |  |  |  | — |
Add: Change in FMV of Equity Awards Granted in Prior Years @ Vesting Date (4) |  | $ | 89,497 |  |  | $ | 60,407 |
Less: FMV of Equity Awards @ the End of the Prior Year Failing to Meet Vesting Conditions |  |  | — |  |  |  | — |
Less: Dollar Value of Equivalent Payments Reported in Summary Compensation Table |  | $ | 166,818 |  |  | $ | 66,927 |
Add: Dollar Value of Dividends Paid Prior to Vesting Date |  | $ | 109,738 |  |  | $ | 25,946 |
2020 Compensation Actually Paid |  | $ | 30,452,042 |  |  | $ | 7,875,351 |
Compensation Actually Paid vs. Total Shareholder Return |  |  |  |
Compensation Actually Paid vs. Net Income |  |  |  |
Compensation Actually Paid vs. Company Selected Measure |  |  |  |
Total Shareholder Return Vs Peer Group |  |  |  |
Tabular List, Table | Measures that were most important to the last fiscal year. The following performance measures reflect the Company’s most important performance measures in effect for 2023, as further described and defined in the Compensation Discussion and Analysis under “Elements of Compensation — Annual Incentive Compensation: PEP” and “Elements of Compensation — Long-Term Equity Incentive Awards — Performance Share Units.”
| • |  | Adjusted EBITDA
| • |  | Earnings Per Share
| • |  | Quality of Care
| • |  | Patient Experience
Total Shareholder Return Amount | $ 188.93 | 165.99 | 175.93 | 111.64
Peer Group Total Shareholder Return Amount | 143.18 | 140.29 | 143.09 | 113.45
Net Income (Loss) | $ 5,242,000,000 | $ 5,643,000,000 | $ 6,956,000,000 | $ 3,754,000,000
Company Selected Measure Amount | 12,726,000,000 | 12,067,000,000 | 12,644,000,000 | 10,037,000,000
PEO Name | Hazen |  |  |
Measure:: 1 |  |  |  |
Pay vs Performance Disclosure |  |  |  |
Name | Adjusted EBITDA |  |  |
Non-GAAP Measure Description | It is a non-Generally Accepted Accounting Principles (“GAAP”) financial measure defined as income before depreciation and amortization, interest expense, losses and gains on sales of facilities, losses on retirement of debt, provision for income taxes and net income attributable to noncontrolling interests. Reconciliations of Adjusted EBITDA to the most directly comparable financial measure calculated in accordance with GAAP are included in Appendix A. |  |  |
Measure:: 2 |  |  |  |
Pay vs Performance Disclosure |  |  |  |
Name | Earnings Per Share |  |  |
Measure:: 3 |  |  |  |
Pay vs Performance Disclosure |  |  |  |
Name | Quality of Care |  |  |
Measure:: 4 |  |  |  |
Pay vs Performance Disclosure |  |  |  |
Name | Patient Experience |  |  |
PEO | Change In Pension Deferred Compensation Plans [Member] |  |  |  |
Pay vs Performance Disclosure |  |  |  |
Adjustment to Compensation, Amount |  |  | $ 451,661 | $ 12,266,548
PEO | Service Cost Of Pension Deferred Compensation Plans [Member] |  |  |  |
Pay vs Performance Disclosure |  |  |  |
Adjustment to Compensation, Amount | $ 723,544 | $ 952,610 | 980,231 | 645,000
PEO | Equity Award Amounts Reported In Summary Compensation [Member] |  |  |  |
Pay vs Performance Disclosure |  |  |  |
Adjustment to Compensation, Amount | 14,200,216 | 12,055,290 | 13,870,607 | 13,082,198
PEO | Fmv Of Equity Awards Granted During Current Year Outstanding Unvested [Member] |  |  |  |
Pay vs Performance Disclosure |  |  |  |
Adjustment to Compensation, Amount | 15,028,391 | 13,374,858 | 34,793,801 | 16,696,602
PEO | Change In Fmv Equity Awards Granted In Prior Years OutstandingUnvested [Member] |  |  |  |
Pay vs Performance Disclosure |  |  |  |
Adjustment to Compensation, Amount | (2,830,010) | (3,338,709) | 33,207,890 | 8,028,998
PEO | Change In Fmv Of Equity Awards Granted In Prior YearS [Member] |  |  |  |
Pay vs Performance Disclosure |  |  |  |
Adjustment to Compensation, Amount | 3,842,051 | (3,998,784) | 9,064,316 | 89,497
PEO | Dollar Value Of Equivalent Payments Reported In Summary Compensation [Member] |  |  |  |
Pay vs Performance Disclosure |  |  |  |
Adjustment to Compensation, Amount | 514,566 | 435,499 | 335,908 | 166,818
PEO | Dollar Value Of Dividends Paid Prior To Vesting Date [Member] |  |  |  |
Pay vs Performance Disclosure |  |  |  |
Adjustment to Compensation, Amount | 226,667 | 445,290 | 545,255 | 109,738
Non-PEO NEO | Change In Pension Deferred Compensation Plans [Member] |  |  |  |
Pay vs Performance Disclosure |  |  |  |
Adjustment to Compensation, Amount | 264,662 | 276,883 | 103,724 | 2,112,322
Non-PEO NEO | Service Cost Of Pension Deferred Compensation Plans [Member] |  |  |  |
Pay vs Performance Disclosure |  |  |  |
Adjustment to Compensation, Amount | 135,006 | 182,990 | 207,139 | 325,250
Non-PEO NEO | Equity Award Amounts Reported In Summary Compensation [Member] |  |  |  |
Pay vs Performance Disclosure |  |  |  |
Adjustment to Compensation, Amount | 3,489,375 | 3,063,442 | 3,233,944 | 2,617,165
Non-PEO NEO | Fmv Of Equity Awards Granted During Current Year Outstanding Unvested [Member] |  |  |  |
Pay vs Performance Disclosure |  |  |  |
Adjustment to Compensation, Amount | 3,692,881 | 2,698,985 | 7,765,175 | 3,335,797
Non-PEO NEO | Change In Fmv Equity Awards Granted In Prior Years OutstandingUnvested [Member] |  |  |  |
Pay vs Performance Disclosure |  |  |  |
Adjustment to Compensation, Amount | (482,970) | (573,313) | 7,116,946 | 1,883,050
Non-PEO NEO | Change In Fmv Of Equity Awards Granted In Prior YearS [Member] |  |  |  |
Pay vs Performance Disclosure |  |  |  |
Adjustment to Compensation, Amount | 642,477 | (737,029) | 1,834,093 | 60,407
Non-PEO NEO | Dollar Value Of Equivalent Payments Reported In Summary Compensation [Member] |  |  |  |
Pay vs Performance Disclosure |  |  |  |
Adjustment to Compensation, Amount | 85,739 | 73,188 | 67,999 | 66,927
Non-PEO NEO | Dollar Value Of Dividends Paid Prior To Vesting Date [Member] |  |  |  |
Pay vs Performance Disclosure |  |  |  |
Adjustment to Compensation, Amount | $ 41,399 | $ 80,563 | $ 111,397 | $ 25,946

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 3 + Details
Name: | ecd_AdjToCompAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 3 + Details
Name: | ecd_AdjToNonPeoNeoCompFnTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 3 + Details
Name: | ecd_AdjToPeoCompFnTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph vi + Details
Name: | ecd_CoSelectedMeasureAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph vi + Details
Name: | ecd_CoSelectedMeasureName
Namespace Prefix: | ecd_
Data Type: | xbrli:normalizedStringItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 5 -Subparagraph iii + Details
Name: | ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 5 -Subparagraph ii + Details
Name: | ecd_CompActuallyPaidVsNetIncomeTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 5 -Subparagraph i + Details
Name: | ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph vi + Details
Name: | ecd_MeasureName
Namespace Prefix: | ecd_
Data Type: | xbrli:normalizedStringItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 3 + Details
Name: | ecd_NamedExecutiveOfficersFnTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph vi + Details
Name: | ecd_NonGaapMeasureDescriptionTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph iii + Details
Name: | ecd_NonPeoNeoAvgCompActuallyPaidAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph ii + Details
Name: | ecd_NonPeoNeoAvgTotalCompAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph iv + Details
Name: | ecd_PeerGroupIssuersFnTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph iv + Details
Name: | ecd_PeerGroupTotalShareholderRtnAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph iii + Details
Name: | ecd_PeoActuallyPaidCompAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 3 + Details
Name: | ecd_PeoName
Namespace Prefix: | ecd_
Data Type: | xbrli:normalizedStringItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph ii + Details
Name: | ecd_PeoTotalCompAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 1 + Details
Name: | ecd_PvpTable
Namespace Prefix: | ecd_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 1 + Details
Name: | ecd_PvpTableTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 6 + Details
Name: | ecd_TabularListTableTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph iv + Details
Name: | ecd_TotalShareholderRtnAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 5 -Subparagraph iv + Details
Name: | ecd_TotalShareholderRtnVsPeerGroupTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(g)(1)(ii)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 825 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 28 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 40 -Name Accounting Standards Codification -Section 65 -Paragraph 1 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 8 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 9 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 11 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 11 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4 Reference 13: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 830 -Name Accounting Standards Codification -Section 55 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section 45 -Paragraph 7 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7 Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Topic 944 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04(18)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1 Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22 Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-07(9)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1 Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-09(1)(d)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3 Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(i)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(ii)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A Reference 21: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iii)(A)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A Reference 22: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iv)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A Reference 23: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(5)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A Reference 24: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(i)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B Reference 25: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(A)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B Reference 26: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(B)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B Reference 27: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iv)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B Reference 28: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(5)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B Reference 29: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 30 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30 Reference 30: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32 Reference 31: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 60B -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B Reference 32: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 31 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31 Reference 33: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32 Reference 34: http://www.xbrl.org/2003/role/disclosureRef -Topic 205 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 7 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7 Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 230 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 28 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28 Reference 36: http://www.xbrl.org/2003/role/disclosureRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 1A -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A Reference 37: http://www.xbrl.org/2003/role/disclosureRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 1B -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03(20)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2 Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 942 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-04(22)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1 + Details
Name: | us-gaap_NetIncomeLoss
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | ecd_MeasureAxis=1
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_MeasureAxis=2
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_MeasureAxis=3
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_MeasureAxis=4
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_ExecutiveCategoryAxis=ecd_PeoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=hca_ChangeInPensionDeferredCompensationPlansMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=hca_ServiceCostOfPensionDeferredCompensationPlansMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=hca_EquityAwardAmountsReportedInSummaryCompensationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=hca_FmvOfEquityAwardsGrantedDuringCurrentYearOutstandingUnvestedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=hca_ChangeInFmvEquityAwardsGrantedInPriorYearsOutstandingunvestedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=hca_ChangeInFmvOfEquityAwardsGrantedInPriorYearsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=hca_DollarValueOfEquivalentPaymentsReportedInSummaryCompensationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=hca_DollarValueOfDividendsPaidPriorToVestingDateMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |